Intensity‐modulated radiotherapy combined with intensity‐modulated radiotherapy CT–guided iodine 125 seed brachytherapy for non‐small cell lung cancer: A case report
Abstract Intensity‐modulated radiotherapy (IMRT) has been used to treat locally advanced non‐small cell lung cancer (LA‐NSCLC) disseminated to primary gross tumor volume (pGTV) and mediastinal lymph nodes (LNs). However, it is challenging to deliver definitive doses to the pGTV and regional LNs with...
Main Authors: | Xinyi Gu, Zhe Wang, Yingming Sun, Liang Yang, Jinyu Wu, Zaishuang Ju, Ruoyu Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2021-06-01
|
Series: | Precision Radiation Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/pro6.1121 |
Similar Items
-
Prostate brachytherapy with iodine-125 seeds: analysis of a single institutional cohort
by: Elton Trigo Teixeira Leite, et al. -
Permanent iodine-125 brachytherapy for patients with progressive or recurrent high-grade gliomas
by: Congxiao Wang, et al.
Published: (2020-06-01) -
Iodine-125 brachytherapy for brain tumours - a review
by: Schwarz Silke B, et al.
Published: (2012-03-01) -
CT‐guided iodine‐125 brachytherapy as salvage therapy for recurrent mediastinal lymph node metastasis
by: Hong Dong, et al.
Published: (2021-05-01) -
Efficacy and safety of iodine-125 brachytherapy combined with chemotherapy in the treatment of advanced NSCLC in the elderly
by: Wu C, et al.
Published: (2018-10-01)